"10.1371_journal.pntd.0000928","plos neglected tropical diseases","2011-01-11T00:00:00Z","Karthik Mallilankaraman; Devon J Shedlock; Huihui Bao; Omkar U Kawalekar; Paolo Fagone; Aarthi A Ramanathan; Bernadette Ferraro; Jennifer Stabenow; Paluru Vijayachari; Senthil G Sundaram; Nagarajan Muruganandam; Gopalsamy Sarangan; Padma Srikanth; Amir S Khan; Mark G Lewis; J Joseph Kim; Niranjan Y Sardesai; Karuppiah Muthumani; David B Weiner","Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Regional Biocontainment Lab, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Regional Medical Research Centers, Indian Council of Medical Research, Port Blair, Andaman & Nicobar Islands, India; Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Chennai, India; Inovio Pharmaceuticals, Blue Bell, Pennsylvania, United States of America; Bioqual Inc, Rockville, Maryland, United States of America","Conceived and designed the experiments: K. Muthumani, D. Weiner. Performed the experiments: K. Mallilankaraman, D. Shedlock, H. Bao, O. Kawalekar, P. Fagone, A. Ramanathan, J. Stabenow, S. Sundaram, N. Muruganandam, G. Sarangan, A. Khan, M. Lewis, K. Muthumani. Analyzed the data: K. Mallilankaraman, D. Shedlock, H. Bao, B. Ferraro, K. Muthumani. Contributed reagents/materials/analysis tools: D. Shedlock, P. Vijayachari, P. Srikanth, J. Kim, N.  Sardesai. Wrote the paper: K. Muthumani, D. Shedlock, K. Mallilankaraman.","The DBW laboratory notes possible commercial conflicts associated with this work, which may include the following: Pfizer, Inovio, BMS, VGXi, Virxsys, Ichor, Novartis, Merck, MVI, Althea, and Aldevron, and possibly others.","2011","01","Karthik Mallilankaraman","KM",19,TRUE,1,1,1,1,TRUE,TRUE,TRUE,12,"3;5;6;7;8;9;10;11;12;13;15;17",TRUE
